175 results on '"Agúndez, José A.G."'
Search Results
2. Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
3. Inflammatory factors and restless legs syndrome: A systematic review and meta-analysis
4. Sleep disorders in tourette syndrome
5. Neurochemical features of idiopathic restless legs syndrome
6. An update on the pharmacogenetic considerations when prescribing dopamine receptor agonists for Parkinson’s disease
7. Vitamin D receptor and binding protein genes variants in patients with migraine
8. Genetics of restless legs syndrome: An update
9. The potential role of pharmacogenomics and biotransformation in hypersensitivity reactions to paracetamol
10. Association between restless legs syndrome and other movement disorders
11. Increased serum diamine oxidase activity in nonallergic patients with migraine
12. Influence of age and gender in motor performance in healthy subjects
13. Neuronal Nitric Oxide Synthase (nNOS, NOS1) rs693534 and rs7977109 Variants and Risk for Migraine
14. Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole
15. Association between restless legs syndrome and peripheral neuropathy: A systematic review and meta‐analysis
16. Deep sequencing of prostaglandin‐endoperoxide synthase ( PTGE) genes reveals genetic susceptibility for cross‐reactive hypersensitivity to NSAID
17. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for and Nonsteroidal Anti‐Inflammatory Drugs
18. LINGO1 gene analysis in Parkinsonʼs disease phenotypes†
19. Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
20. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs
21. An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding
22. An Update on the Neurochemistry of Essential Tremor
23. PharmVar GeneFocus: CYP2D6
24. Variability in Ethanol Biodisposition in Whites Is Modulated by Polymorphisms in the Adh1b and Adh1c Genes
25. Motor performance in patients with restless legs syndrome
26. Histamine-N-Methyl Transferase Polymorphism and Risk for Migraine
27. Changes at the CYP2C Locus and Disruption of CYP2C8/9 Linkage Disequilibrium in Patients With Essential Tremor
28. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population.
29. Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease
30. Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk
31. CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity
32. PharmVar GeneFocus: CYP2D6.
33. TREM2 R47H variant and risk of essential tremor: A cross-sectional international multicenter study
34. The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome
35. Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome
36. Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease
37. NAT2 polymorphisms and risk for Parkinson’s disease: a systematic review and meta-analysis
38. SLC1A2 rs3794087 variant and risk for essential tremor
39. Association Between Vitamin D Receptor rs731236 (Taq1) Polymorphism and Risk for Restless Legs Syndrome in the Spanish Caucasian Population
40. LINGO1 rs9652490 and rs11856808 are not associated with the risk of Parkinson’s disease: Results of a meta-analysis
41. The Relationship Between Parkinson���s Disease and Essential Tremor: Review of Clinical, Epidemiologic, Genetic, Neuroimaging and Neuropathological Data, and Data on the Presence of Cardinal Signs of Parkinsonism in Essential Tremor
42. Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis
43. Neuronal Nitric Oxide Synthase(nNOS,NOS1) rs693534 and rs7977109 Variants and Risk for Migraine
44. Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome
45. Drug metabolism and hypersensitivity reactions to drugs
46. Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor
47. Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole
48. COMT gene and risk for Parkinson’s disease
49. SLC1A2 rs3794087 variant and risk for migraine
50. PITX3 and Risk for Parkinson's Disease: A Systematic Review and Meta-Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.